REGISTERED COMPANY NUMBER: CE025306(England and Wales)
REGISTERED CHARITY NUMBER: 1194608
Report of the Trustees and
Unaudited Financial Statements for the Period 27 May 2021 to
31 December 2021
for
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Contents of the Financial Statements
for the Period 27 May 2021 to 31 December 2021
|
Page |
Report of the Trustees |
1 to 2 |
Statement of Financial Activities |
3 |
Balance Sheet |
4 |
Notes to the Financial Statements |
5 to 6 |
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Report of the Trustees for the Period 27 May 2021 to 31 December 2021
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006, present
theirreportwith the financialstatementsof the charityfor the period27 May 2021to 31 December 2021.
ThetrusteeshaveadoptedtheprovisionsoftheStatementofRecommendedPractice(SORP) 'Accounting
and Reporting by Charities' issued in March 2005.
The Charity was inactive in the year. It begun operations on 1st January 2022.
INCORPORATION
The charitable company was incorporated on 27 May 2021 and commenced trading on 1 January 2022.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
CE025306 (England and Wales)
Registered Charity number
1194608
Registered office
Clocktower
Mount Vernon Hospital
Rickmansworth Road
Northwood
HA6 2RN
Trustees
Trustees |
|
R J Hallam |
- appointed 27.5.2021 |
Dr. P Nathan |
- appointed 27.5.2021 |
Dr A Sharma |
- appointed 27.5.2021 |
Dr A Polychronis |
- appointed 27.5.2021 |
Dr D J Pinato |
- appointed 27.5.2021 |
Professor M Hall |
- appointed 27.5.2021 |
Professor M J Seckl |
- appointed 27.5.2021 |
Professor G Rustin |
- appointed 27.5.2021 |
Company Secretary
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrust,andconstitutesalimited company,
limited by guarantee, as defined by the Companies Act 2006.
Risk management
Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure
appropriate controls are in place to provide reasonable assurance against fraud and error.
Page 1
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Report of the Trustees
for the Period 27 May 2021 to 31 December 2021
Approved by order of the board of trustees on 30 August 2023 and signed on its behalf by:
Professor M Hall - Trustee
Page 2
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Statement of Financial Activities
for the Period 27 May 2021 to 31 December 2021
Notes£
TOTAL FUNDS CARRIED FORWARD-
The notes form part of these financial statements
Page 3
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Balance Sheet At 31 December 2021
Notes
TOTAL ASSETS LESS CURRENT LIABILITIES
NET ASSETS
FUNDS
3
TOTAL FUNDS |
£
- |
|
- |
|
|
|
- |
The charitablecompanyis entitledto exemptionfromauditunderSection477of the CompaniesAct 2006
for the period ended 31 December 2021.
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsforthe period
ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
Thesefinancialstatementshavebeenpreparedin accordancewiththespecialprovisionsof Part15of the
CompaniesAct2006relatingtocharitablesmallcompaniesandwiththeFinancialReportingStandard for
Smaller Entities (effective January 2015).
ThefinancialstatementswereapprovedbytheBoardofTrusteeson30August2023andweresigned on
its behalf by:
Professor M Hall -Trustee
The notes form part of these financial statements
Page 4
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Notes to the Financial Statements
for the Period 27 May 2021 to 31 December 2021
1. ACCOUNTING POLICIES
Accounting convention
Thefinancialstatementshavebeenpreparedunderthehistoricalcostconvention,and in
accordancewiththeFinancialReportingStandardforSmallerEntities(effectiveApril2008), the
CompaniesAct 2006and the requirementsof the Statementof RecommendedPractice, Accounting
and Reporting by Charities.
The charitable company was dormant throughout the period ended 31 December 2021.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
2. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the period ended 31 December 2021.
Trustees' expenses
There were no trustees' expenses paid for the period ended 31 December 2021.
3. MOVEMENT IN FUNDS
|
|
Net |
|
|
|
movement |
|
|
|
in funds |
At 31/12/21 |
|
|
£ |
£ |
TOTAL FUNDS |
|
- |
- |
Net movement in funds, included in the above are as follows: |
|
|
|
|
Incoming |
Resources |
Movement |
|
resources |
expended |
in funds |
|
£ |
£ |
£ |
Page 5
THE CANCER TREATMENT AND RESEARCH TRUST
CIO
Notes to the Financial Statements - continued
for the Period 27 May 2021 to 31 December 2021
3. MOVEMENT IN FUNDS - continued
TOTAL FUNDS---
Page 6